Contact this trialFirst, we need to learn more about you.
Tyrosine Kinase Inhibitor
CG-806 for Acute Myeloid Leukemia and High-Risk MDS
Recruiting1 awardPhase 1
Los Angeles, California
This trial is testing a new drug, CG-806, to see if it is safe and effective in treating patients with leukemia or MDS who have relapsed or are unresponsive to other treatments.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service